Literature DB >> 25524369

Gentio-oligosaccharides from Leuconostoc mesenteroides NRRL B-1426 dextransucrase as prebiotics and as a supplement for functional foods with anti-cancer properties.

Damini Kothari1, Arun Goyal.   

Abstract

Gentio-oligosaccharides (GnOS) were synthesized by the acceptor reaction of dextransucrase from Leuconostoc mesenteroides NRRL B-1426 with gentiobiose and sucrose. GnOS were purified by gel permeation chromatography using a Bio-Gel P-2 column and identified by mass spectrometry. The purified GnOS (degree of polymerization ≥3) were investigated for their in vitro prebiotic and cytotoxic activity. GnOS exhibited a significantly lower degree of digestibility of 18.1% by simulated human gastric juice (pH 1.0) and 7.1% by human α-amylase (pH 7.0) after 6 h, whereas inulin, a standard prebiotic, showed 39.7% and 12.8% of digestibility, respectively. The prebiotic score showed that GnOS significantly supported the growth of probiotics such as Bifidobacterium infantis and Lactobacillus acidophilus and was comparable to that of inulin. The selective inhibitory effect of GnOS on human colon carcinoma (HT-29) cells revealed its potential as an anti-cancer agent that can serve as a functional food additive for the benefit of human health.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25524369     DOI: 10.1039/c4fo00802b

Source DB:  PubMed          Journal:  Food Funct        ISSN: 2042-6496            Impact factor:   5.396


  10 in total

1.  Characterization of new oligosaccharide converted from cellobiose by novel strain of Bacillus subtilis.

Authors:  Hoon Kim; Sue Jung Lee; Kwang-Soon Shin
Journal:  Food Sci Biotechnol       Date:  2017-11-13       Impact factor: 2.391

2.  In vitro prebiotic potential, digestibility and biocompatibility properties of laminari-oligosaccharides produced from curdlan by β-1,3-endoglucanase from Clostridium thermocellum.

Authors:  Krishan Kumar; Vikky Rajulapati; Arun Goyal
Journal:  3 Biotech       Date:  2020-05-09       Impact factor: 2.406

3.  Draft Genome Sequence of Three Antibiotic-Resistant Leuconostoc mesenteroides Strains of Dairy Origin.

Authors:  Ilenia Campedelli; Ana Belén Flórez; Elisa Salvetti; Susana Delgado; Luigi Orrù; Luigi Cattivelli; Ángel Alegría; Giovanna E Felis; Sandra Torriani; Baltasar Mayo
Journal:  Genome Announc       Date:  2015-09-10

4.  Construction of a Recombinant Leuconostoc mesenteroides CJNU 0147 Producing 1,4-Dihydroxy-2-Naphthoic Acid, a Bifidogenic Growth Factor.

Authors:  Ji-Eun Eom; Gi-Seong Moon
Journal:  Korean J Food Sci Anim Resour       Date:  2015-12-31       Impact factor: 2.622

5.  Isolation and Structural Characterization of an Oligosaccharide Produced by Bacillus subtilis in a Maltose-Containing Medium.

Authors:  Kwang-Soon Shin
Journal:  Prev Nutr Food Sci       Date:  2016-06-30

6.  Structural Analysis of Gluco-Oligosaccharides Produced by Leuconostoc lactis and Their Prebiotic Effect.

Authors:  Sulhee Lee; Jisun Park; Jae-Kweon Jang; Byung-Hoo Lee; Young-Seo Park
Journal:  Molecules       Date:  2019-11-05       Impact factor: 4.411

7.  Production Optimization, Structural Analysis, and Prebiotic- and Anti-Inflammatory Effects of Gluco-Oligosaccharides Produced by Leuconostoc lactis SBC001.

Authors:  Minhui Kim; Jae-Kweon Jang; Young-Seo Park
Journal:  Microorganisms       Date:  2021-01-19

8.  Enzymatic Preparation of Gentiooligosaccharides by a Thermophilic and Thermostable β-Glucosidase at a High Substrate Concentration.

Authors:  Wei Xia; Lingling Sheng; Wanmeng Mu; Yuping Shi; Jing Wu
Journal:  Foods       Date:  2022-01-26

Review 9.  Recent advancements in prebiotic oligomers synthesis via enzymatic hydrolysis of lignocellulosic biomass.

Authors:  Reetu Saini; Anil Kumar Patel; Jitendra Kumar Saini; Chiu-Wen Chen; Sunita Varjani; Reeta Rani Singhania; Cheng Di Dong
Journal:  Bioengineered       Date:  2022-02       Impact factor: 3.269

Review 10.  Selective Manipulation of the Gut Microbiota Improves Immune Status in Vertebrates.

Authors:  Ana Montalban-Arques; Peter De Schryver; Peter Bossier; Gregor Gorkiewicz; Victoriano Mulero; Delbert Monroe Gatlin; Jorge Galindo-Villegas
Journal:  Front Immunol       Date:  2015-10-09       Impact factor: 7.561

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.